U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C18H22NO3S.Br
Molecular Weight 412.341
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HETERONIUM BROMIDE

SMILES

[Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C2=CC=CS2)C3=CC=CC=C3

InChI

InChIKey=SHPIBZXFYWMQBR-UHFFFAOYSA-M
InChI=1S/C18H22NO3S.BrH/c1-19(2)11-10-15(13-19)22-17(20)18(21,16-9-6-12-23-16)14-7-4-3-5-8-14;/h3-9,12,15,21H,10-11,13H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI

Description

Heteronium is an anticholinergic agent. As a bromide salt, it was investigated in the clinic for the treatment of peptic ulcer and other gastrointestinal disorders.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Evaluation of the antisecretory effect of a new anticholinergic agent--heteronium bromide.
1969-05
A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety.
1968-10
Name Type Language
31814
Preferred Name English
HETERONIUM BROMIDE
INN   MI   USAN  
INN   USAN  
Official Name English
HETERONIUM BROMIDE [USAN]
Common Name English
.ALPHA.+.BETA.-(±)-(1-METHYL-3-PYRROLIDINYL) .ALPHA.-PHENYL-.ALPHA.-(2-THIENYL)GLYCOLATE METHOBROMIDE
Common Name English
heteronium bromide [INN]
Common Name English
PYRROLIDINIUM, 3-((2-HYDROXY-2-PHENYL-2-(2-THIENYL)ACETYL)OXY)-1,1-DIMETHYL-, BROMIDE (1:1)
Systematic Name English
HETERONIUM BROMIDE [MI]
Common Name English
PYRROLIDINIUM, 3-((HYDROXYPHENYL-2-THIENYLACETYL)OXY)-1,1-DIMETHYL-, BROMIDE
Systematic Name English
(±)-HETERONIUM BROMIDE
Common Name English
(±)-3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE .ALPHA.-PHENYL-2-THIOPHENEGLYCOLATE
Systematic Name English
HETRUM BROMIDE
Common Name English
Code System Code Type Description
NCI_THESAURUS
C174630
Created by admin on Mon Mar 31 18:44:27 GMT 2025 , Edited by admin on Mon Mar 31 18:44:27 GMT 2025
PRIMARY
ChEMBL
CHEMBL2110853
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY
FDA UNII
B41610WX8O
Created by admin on Mon Mar 31 18:44:27 GMT 2025 , Edited by admin on Mon Mar 31 18:44:27 GMT 2025
PRIMARY
EPA CompTox
DTXSID20993288
Created by admin on Mon Mar 31 18:44:27 GMT 2025 , Edited by admin on Mon Mar 31 18:44:27 GMT 2025
PRIMARY
CAS
7247-57-6
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY
INN
1628
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY
EVMPD
SUB08022MIG
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY
MESH
C014023
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY
SMS_ID
100000083952
Created by admin on Mon Mar 31 18:44:27 GMT 2025 , Edited by admin on Mon Mar 31 18:44:27 GMT 2025
PRIMARY
PUBCHEM
13964
Created by admin on Mon Mar 31 18:44:27 GMT 2025 , Edited by admin on Mon Mar 31 18:44:27 GMT 2025
PRIMARY
MERCK INDEX
m230
Created by admin on Mon Mar 31 18:44:26 GMT 2025 , Edited by admin on Mon Mar 31 18:44:26 GMT 2025
PRIMARY Merck Index
ACTIVE MOIETY
Structure of HETERONIUM
SUBSTANCE RECORD
Structure of HETERONIUM BROMIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966